Cyclic angiogenesis process in the ovary;Zyklische angiogeneseprozesse im ovar: Voraussetzung fur ungestorte reproduktionstatigkeit und experimentelles modell fur tumorangiogene prozesse

Gynakologe

Volumn 32, Issue 7, 1999, Pages 582-589

  Augustin, H G ^a   Kuhn, W ^b  

^a UNIVERSITY OF GÖTTINGEN   (Germany)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ANGIOGENESIS; CELL REGENERATION; CORPUS LUTEUM FUNCTION; ESTROGEN BLOOD LEVEL; MORPHOLOGY; OVARY CYCLE; REVIEW;

EID: 0032775638     PISSN: 00175994     EISSN: None     Source Type: Journal    
DOI: 10.1007/s001290050467     Document Type: Review

References (60)

1. Alon T, Hemo I, Itin A, Pe'er J, Stone J, Keshet E (1995) Vascular endothelial growth factor acts as a survival factor for newly formed retinal vessels and has implications for retinopathy of prematurity. Nat Med 1, 1024-1028.
2. Augustin HG (1998) Antiangiogenic tumor therapy: will it work? Trends Pharmacol Sci 19:216-222
3. Augustin HG (1999) Development of the vascular system in the corpus luteum. In: Risau W (ed): Morphogenesis of Endothelium. Harwood Academic Publishers, im Druck.
4. Augustin HG, Braun K, Telemenakis I, Modlich U, Kuhn W (1995) Ovarian angiogenesis: phenotypic characterization of endothelial cells in a physiological model of blood vessel growth and regression. Am J Pathol 147:1-13
5. Baird A, Hsueh AJ (1986) Fibroblast growth factor as an intraovarian hormone: differential regulation of steroidogenesis by an angiogenic factor. Regul Pept 16:243-250
6. Benjamin LE, Hemo I, Keshet E (1998) A plasticity window for blood vessel remodelling is defined by pericyte coverage of the preformed endothelial network and is regulated by PDGF-B and VEGF. Development 125: 1591-1598
7. Benjamin LE, Keshet E (1997) Conditional switching of vascular endothelial growth factor (VEGF) expression in tumors: induction of endothelial cell shedding and regression of hemangioblastoma-like vessels by VEGF withdrawal. Proc Natl Acad Sci USA 94:8761-8766
8. Boehm T, Folkman J, Browder T, O'Reilly MS (1997) Antiangiogenic therapy of experimental cancer does not induce acquired drug resistance. Nature 390:404-407
9. Carmeliet P, Ferreira V, Breier G, Pollefeyt S, Kieckens L, Gertsenstein M, et al. (1996) Abnormal blood vessel development and lethality in embryos lacking a single VEGF allele. Nature 380, 435-439
10. Ferrara N, Chen H, Davis-Smyth T, Gerber HP, Nguyen TN, Peers D, et al. (1998) Vascular endothelial growth factor is essential for corpus luteum angiogenesis. Nat Med 4:336-340
11. Ferrara N, Davis-Smyth T (1997) The biology of vascular endothelial growth factor. Endocr Rev 18:4-25
12. Ferrara N, Carver-Moore K, Chen H, Dowd M, Lu L, O'Shea KS et al. (1996) Heterozygous embryonic lethality induced by targeted inactivation of the VEGF gene. Nature 380: 439-442
13. Folkman J (1996) Fighting cancer by attacking its blood supply. Sci Am 275:150-144
14. Fotsis T, Zhang Y, Pepper MS, Adlercreutz H, Montesano R, Nawroth PP, et al. (1994) The endogenous oestrogen metabolite 2-methoxyoestradiol inhibits angio-genesis and suppresses tumour growth. Nature 368:237-239
15. Gagliardi AR, Collins DC (1993) Inhibition of angiogenesis by antiestrogens. Cancer Res 153:533-535
16. Goede V, Borgelli L, Ziche M, Augustin HG (1999) Induction of inflammatory angiogenesis by monocyte chemoattractant protein-1 (MCP-1). Int J Cancer, im Druck
17. Goede V, Schmidt T, Kimmina S, Kozian DH, Augustin HG (1998) Analysis of blood vessel maturation processes during cyclic ovarian angiogenesis. Lab Invest, 78:1385-1394
18. Gordon JD, Shifren JL, Foulk RA, Taylor RN, Jaffe RB (1995) Angiogenesis in the human female reproductive tract. Obstet Gynecol Surv 50:688-697
19. Gospodarowicz D, Cheng J, Lui GM, Baird A, Esch F, Bohlen P (1985) Corpus luteum angiogenic factor is related to fibroblast growth factor. Endocrinology 117:2383-2391
20. Gospodarowicz D, Thakral KK (1978) Production of a corpus luteum angiogenic factor responsible for proliferation of capillaries and neovascularization of the corpus luteum. Proc Natl Acad Sci USA 75:847-851
21. Hanahan D (1997) Signaling vascular morphogenesis and maintenance. Science 277: 48-50
22. Harris AL (1997) Antiangiogenesis for cancer therapy. Lancet 349SII: 13-15
23. Höflinger H (1948) Das Ovar des Rindes in den verschiedenen Lebensperioden unter besonderer Berücksichtigung seiner funktionellen Feinstruktur. Acta Anat, Suppl. 5, Basel, New York: Karger.
24. Jakob W, Jentzsch KD, Mauersberger B, Oehme P (1977) Demonstration of angiogenesisactivity in the corpus luteum of cattle. Exp Pathol 13:231-236
25. Johns A, Freay AD, Fraser W, Korach KS, Rubanyi GM (1996) Disruption of estrogen receptor gene prevents 17 beta estradiol-induced angiogenesis in transgenic mice. Endocrinology 137:4511-4513
26. Kamat BR, Brown LF, Manseau EJ, Senger DR, Dvorak HF (1995) Expression of vascular permeability factor/vascular endothelial growth factor by human granulosa and theca lutein cells: role in corpus luteum development. Am J Pathol 146:157-165
27. Kim-Schulze S, McGowan KA, Hubchak SC, Cid MC, Martin MB, Kleinman HK, et al. (1996) Expression of an estrogen receptor by human coronary artery and umbilical vein endothelial cells. Circulation 94:1402-1407
28. Klauber N, Rohan RM, Flynn E, D'Amato RJ (1997) Critical components of the female reproductive pathway are suppressed by the angiogenesis inhibitor AGM-1470. Nat Med 4:443-446
29. Koos RD (1986) Stimulation of endothelial cell proliferation by rat granulosa cell-conditioned medium. Endocrinology 119:481-489
30. Maisonpierre PC, Suri C, Jones PF, Bartunkova S, Wiegand SJ, Radziejewski C, et al. (1997) Angiopoietin-2, a natural antagonist for Tie2 that disrupts in vivo angio-genesis. Science 277:55-60
31. McClure N, Healy DL, Rogers PA, Sullivan J, Beaton L, Haning RV, et al. (1994) Vascular endothelial growth factor as capillary permeability agent in ovarian hyperstimulation syndrome. Lancet 344:235-236
32. McLaren J, Prentice A, Charnock-Jones DS, Millican SA, Muller KH, Sharkey AM, et al. (1996) Vascular endothelial growth factor is produced by peritoneal fluid macrophages in endometriosis and is regulated by ovarian steroids. J Clin Invest 98:482-489
33. Messinis IE (1997) Luteal function - luteolysis. Ann NY Acad Sci 816:151-157
34. Meyer GT, McGeachie JK (1988) Angiogenesis in the developing corpus luteum of pregnant rats: a stereologic and autoradiographic study. Anat Rec 222:18-25
35. Modlich U, Kaup FJ, Augustin HG (1996) Cyclic angiogenesis and blood vessel regression in the ovary: blood vessel regression during luteolysis involves endothelial cell detachment and vessel occlusion. Lab Invest 74:771-780
36. Morales DE, McGowan KA, Grant DS, Maheshwari S, Bhartiya D, Cid MC, et al. (1995) Estrogen promotes angiogenic activity in human umbilical vein endothelial cells in vitro and in a murine model. Circulation 91: 755-763
37. Murdoch WJ, Steadman LE (1991) Investigations concerning the relationship of ovarian eosinophilia to ovulation and luteal function in the sheep. Am J Reprod Immunol 25: 81-87
38. Naftalin DM, Bove SE, Keyes PL, Townson DH (1997) Estrogen withdrawal induces macrophage invasion in the rabbit corpus luteum. Biol Reprod 56:1175-1180
39. Neufeld G, Ferrara N, Schweigerer L, Mitchell R, Gospodarowicz D (1987) Bovine granulosa cells produce basic fibroblast growth factor. Endocrinology 121:597-603
40. Neulen J, Van Z, Raczek S, Weindel K, Keck C, Weich HA, et al. (1995) Human chorionic gonadotropin-dependent expression of vascular endothelial growth factor/vascular permeability factor in human granulosa cells: importance in ovarian hyperstimulation syndrome. J Clin Endocrinol Metan 80:1967-1971
41. Petrovska M, Dimitrov DG, Michael SD (1996) Quantitative changes in macrophage distribution in normal mouse ovary over the course of the estrous cycle examined with an image analysis system. Am J Reprod Immunol 36:175-183
42. Ravindranath N, Little-Ihrig L, Phillips HS, Ferrara N, Zeleznik AJ (1992) Vascular endothelial growth factor messenger ribonucleic acid expression in the primate ovary. Endocrinology 131:254-260
43. Reynolds LP, Redmer DA (1998) Expression of the angiogenic factors, basic fibroblast growth factor and vascular endothelial growth factor, in the ovary. J Anim Sci 76:1671-1681
44. Reynolds LP, Killilea SD, Redmer DA (1992). Angiogenesis in the female reproductive system. FASEB J 6:886-892
45. Richards JS (1980) Maturation of ovarian follicles: actions and interactions of pituitary and ovarian hormones on follicular cell differentiation. Physiol Rev 60:51-89
46. Rizk B, Aboulghar M, Smitz J, Ron-El R (1997) The role of vascular endothelial growth factor and interleukins in the pathogenesis of severe ovarian hyperstimulation syndrome. Hum Reprod Update 3, 255-266
47. Rodger FE, Young FM, Fraser HM, Illingworth PJ (1997) Endothelial cell proliferation follows the mid-cycle luteinizing hormone surge, but not human chorionic gonadotrophin rescue, in the human corpus luteum. Hum Reprod 12:1723-1729
48. Rone JD, Halvorson LM, Goodman AL (1993) Ovarian angiogenesis in rabbits: endotheliotrophic chemoattractant activity from isolated follicles and dispersed granulosa cells. J Reprod Fertil 97:359-365
49. Rone JD, Goodman AL (1990) Preliminary characterization of angiogenic activity in media conditioned by cells from luteinized rat ovaries. Endocrinology 127:2821-2828
50. Sato E, Ishibashi T, Koide SS (1982) Inducement of blood vessel formation by ovarian extracts from mice injected with gonadotropins. Experientia 15:1248-1249
51. Schnaper HW, McGowan KA, Kim-Schulze S, Cid MC (1996) Oestrogen and endothelial cell angiogenic activity. Clin Exp Pharmacol Physiol 23:247-50
52. Shifren JL, Tseng JF, Zaloudek CJ, Ryan IP, Meng YG, Ferrara N, et al. (1996) Ovarian steroid regulation of vascular endothelial growth factor in the human endometrium: implications for angiogenesis during the menstrual cycle and in the pathogenesis of endometriosis. J Clin Endocrinol Metab 81: 3112-3118
53. Shimasaki S, Emoto N, Koba A, Mercado M, Shibata F, Cooksey K, et al. (1988) Complementary DNA cloning and sequencing of rat ovarian basic fibroblast growth factor and tissue distribution study of its mRNA. Biochem Biophys Res Commun 157:256-263
54. Shweiki D, Itin A, Neufeld G, Gitay-Goren H, Keshet E (1993) Patterns of expression of vascular endothelial growth factor (VEGF) and VEGF receptors in mice suggest a role in hormonally regulated angiogenesis. J Clin Invest 91:2235-2243
55. Takaya R, Fukaya T, Sasano H, Suzuki T, Tamura M, Yajima A (1997) Macrophages in normal cycling human ovaries; immunohistochemical localization and characterization. Hum Reprod 12:1508-1512
56. Townson DH, Warren JS, Flory CM, Naftalin DM, Keyes PL (1996) Expression of monocyte chemoattractant protein-1 in the corpus luteum of the rat. Biol Reprod 54:513-520
57. Vinatier D, Dufour P, Tordjeman-Rizzi N, Prolongeau JF, Depret-Moser 5, Monnier JC (1995) Immunological aspects of ovarian function: role of the cytokines. Eur J Obstet Gynecol Reprod Biol 63:155-168
58. Wiltbank MC, Gallagher KP, Christensen AK, Brabec RK, Keyes PL (1990) Physiological and immunocytochemical evidence for a new concept of blood flow regulation in the corpus luteum. Biol Reprod 42:139-149
59. Yamamoto T, Terada N, Nishizawa Y, Petrow V (1994) Angiostatic activities of medroxyprogesterone acetate and its analogues. Int J Cancer 56:393-399
60. Zheng J, Redmer DA, Reynolds LP (1993) Vascular development and heparin-binding growth factors in the bovine corpus luteum at several stages of the estrous cycle. Biol Reprod 49:1177-1189